Loading...

The global impact of Precision Medicine Group.
As it happens.

Impact, observations, and insights on the evolving healthcare landscape.

Event: Cell & Gene Reception @ BIO, 2023

2023-05-23T13:40:58-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision is honored to be a co-host of this year’s ARM Cell & Gene Reception @ BIO, May 5, 2023, in Boston, MA. Attendees will enjoy extensive networking opportunities with the sector’s top decision makers including executives from leading companies located in the Boston area!

Connect with our Advanced Therapy experts!

  • Date: Monday, June 5, 2023
  • Time: 6:00pm – 9:00pm ET
  • Location: Woods Hill Pier 4, Boston, MA

Registration is complimentary – CLICK HERE to reserve your spot.

(more…)

Read More

Conference: ASGCT, 2023

2023-05-17T10:37:09-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at this year’s ASGCT, May 16-20, 2023, in Los Angeles, CA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the development for cell and gene therapies.

Connect with our Advanced Therapy experts!

  • Visit us at booth 754 in the exhibition area
  • Be sure to attend Precision’s own, Travis Harrison’s presentation on May 19, 2023, at 4:45PM PDT – 5:15PM PDT

You can register for ASGCT below:

REGISTER HERE

(more…)

Read More

On Demand: Cell and Gene Therapies – How High Can Prices Go?

2023-07-18T16:07:02-04:00Cell & Gene Therapy, Events, Thought Leadership|

Join our experts on April 26, 2023 at 9AM EST as we dive into a powerful 30 minute webinar followed by live Q&A.

This ON24 webinar will discuss how cell and gene therapies can be justifiably priced at different levels. We will explore just how high they can extend and also how we can collectively ensure that patients can access these innovations when they are needed. This discussion will be led by David Carr: Senior Director, Global Pricing and Market Access (PRECISIONadvisors), Richard Macaulay: SVP, Global Pricing and Market Access (PRECISIONadvisors).

(more…)

Read More

White Paper: “Preventative” Gene Therapies: Perspectives on Payer Access Challenges and Solutions

2023-11-09T08:32:51-05:00Cell & Gene Therapy, News, Thought Leadership|

Gene therapies offer hope for patients with severe genetic diseases by providing long-term benefits and even cures. However, the challenges of evaluating the long-term benefits of these therapies from a payer perspective are considerable. This white paper by PRECISIONadvisors highlights the shift of gene therapy research into more prevalent diseases, and outlines how manufacturers and payers can co—create evidence requirements and models to optimize launch success and sustainability.

(more…)

Read More

Conference: Meeting on the Med, 2023

2023-04-05T02:55:47-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at this year’s Meeting on the Med, April 12-14, 2023, in Barcelona, Spain. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization for cell and gene therapies.

Connect with our Advanced Therapy experts

  • Visit us through any of the numerous networking opportunities at Meeting on the Med 23′
  • Be sure to attend the ADVANCE sponsored workshop on April 12, 2023, at 4:45PM – 5:30PM CET |Location: Hotel Arts Barcelona (BioCentriq Ballroom: Gaudi 3)

You can register for Meeting on the Med below:

REGISTER HERE

(more…)

Read More

Conference: Gene Therapy for Rare Disorders (GTRD), 2023

2023-03-14T10:37:26-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at this year’s Gene Therapy for Rare Disorders on March 20-23, 2023, in Boston, MA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization for gene therapies.

Speaking Engagements
Detailed descriptions for each speaking engagement are included below. 

  • Precision ADVANCE will have a plenary speaking position on March 21, 2023, 8:30 – 9:00 am.
  • Project Farma will be facilitating a plenary panel discussion ” Current Trends in Technical Operations for Rare Disorders” on March 21, 2023, 10:45 – 11:15 am.
  • Project Farma’s Tony Khoury (EVP, Project Farma) will be joining the Manufacturing track panel discussion, “Capacity versus Capability – Moving Towards Innovative Manufacturing Processes,” on March 21, 2023, 11:15 – 11:45 am.
  • Precision ADVANCE will hold a drinks reception on March 21, 2023, at 6:10 pm in the Grand & Liberty Ballroom.

Connect with our Advanced Therapy experts

  • Visit us at booth 13 in the exhibition area
  • Schedule in-person or virtual meetings by clicking here: https://bit.ly/precisionmedicinegrp
  • Attend our ADVANCE-sponsored Drinks Reception on March 21, 2023, at 6:10 PM ET

—

Plenary Speaking Position: Successfully Launching a Gene Therapy with Cynthia Pussinen & Dave Lennon
Precision ADVANCE | March 21, 2023, 8:30 – 9AM ET 

  • Key Takeaways
    • Identify active strategies to enable a smooth plan from preclinical development to commercialization
    • New approaches for regulatory approval and commercialization
    • Anticipating and overcoming potential hurdles specific to gene therapies
    • The future of the industry

Speakers:

  • Anshul Mangal: President (Project Farma & Precision ADVANCE)
  • Cynthia Pussinen: Former CTO (Spark Therapeutics Inc.)
  • Dave Lennon: CEO (Satellite Bio)

Panel Discussion: Current Trends in Technical Operations for Rare Disorders
Project Farma | March 21, 2023, 10:45-11:15AM ET

  • Key Takeaways
    • Current trends impacting manufacturing of gene therapies including capital markets, supply chain and technologies
    • Shifts in technical operations as a result of current trends
    • Opportunities and innovations in technical operations that can transform the industry

Speakers:

  • [Moderator] Charlie Harper: Vice President, Consulting (Project Farma)
  • Greg Gara: Senior Vice President (Project Farma)
  • Tony Khoury: Executive Vice President (Project Farma)
  • Eric Hacherl: Vice President, Manufacturing (Spark Therapeutics, Inc.)

Panel Discussion: Manufacturing Track: Capacity versus Capability – Moving Towards Innovative Manufacturing Processes
Project Farma | March 21, 2023, 11:15 – 11:45AM ET

  • Greg Gara: Senior Vice President (Project Farma) to join
Read More

White Paper: What’s Next for Cell and Gene Therapies in 2023 and Beyond

2023-02-09T13:57:47-05:00Cell & Gene Therapy, Thought Leadership|

The cell and gene therapy (CGTx) sector has flourished in recent years due to continued investor confidence. However, the present downturn in public markets has negatively affected that confidence, raising questions about the sector’s prospects for 2023 and beyond.

This white paper is based on a panel discussion at the Cell & Gene Meeting on the Mesa (October 11, 2022), sponsored by Precision ADVANCE, focusing on the future of advanced therapies. The panel included insights from the following industry leaders:

  • Anshul Mangal: President (Project Farma & Precision ADVANCE)
  • Stewart Abbot: Chief Scientific Officer (Turnstone Biologics)
  • Laura Lande-Diner: Chief Business Officer (Satellite Bio)
  • Robert Peters: Chief Scientific Officer (Ensoma)
  • Deborah Phippard: Chief Scientific Officer (Precision For Medicine)

(more…)

Read More

White Paper: State of the Union for Advanced Medicines

2023-02-09T10:41:09-05:00Cell & Gene Therapy, Thought Leadership|

The cell and gene therapy (CGTx) sector has flourished over the last 2 to 5 years due to continued investor confidence. However, the recent downturn in public markets has undermined that confidence.

This white paper is based on a panel discussion, sponsored by Precision ADVANCE, featuring insights from diverse industry perspectives on the current state of the CGTx sector; the investment landscape; scientific and technical advances; progress in drug development, manufacturing, regulatory, pricing, and reimbursement; and expected key trends in 2023 and beyond. Hosted by Endpoints News, the panel included insights from the following industry leaders:

  • Anshul Mangal: President (Project Farma & Precision ADVANCE)
  • Dave Greenwald: Vice President of Business Development (Deerfield Management)
  • Rajul Jain: Managing Director (Vida Ventures)
  • Joseph LaBarge: Chief Executive Officer (Apertura Gene Therapy)
  • Adrian Woolfson: Executive Chairman, President and Co-Founder (Replay Bio)
  • Phil Cyr: Executive Vice President (Precision Value & Health)

(more…)

Read More

Webinar: A Crisis in Rare Disease

2022-09-02T07:58:15-04:00Cell & Gene Therapy, Events, Thought Leadership|

There is a big need for therapeutic advancement in the rare disease community – however, public markets are stifling innovation and development for advanced medicines. This webinar, on Thursday, September 15th, will examine the current markets, their effect on the innovation in rare disease drug development, and what we can do to help.

Sponsored by Precision ADVANCE, this panel features insights from industry leaders on their organization’s pipeline, the advanced therapy investment landscape, and the innovation, manufacturing, and community needs to successfully bring an advanced therapy to market. This discussion will be moderated by Anshul Mangal (President, Project Farma & Precision ADVANCE), and include insights from Alex Karnal (Founder, Braidwell), Chidozie Ugwumba (Managing Partner, Symbiosis), James Wilson (Director, Perelman School of Medicine, UPenn), and Tony Khoury (EVP, Project Farma).

Key points to be discussed:

  • Learn about the current state of investments for the rare disease sector
  • Understand the market’s effect on innovation in rare disease
  • Hear from leading experts on what we do as a community to help drive innovation forward

 

REGISTER NOW

Read More
Load More Posts

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

© Precision Medicine Group, LLC.
All Rights Reserved.